It has been previously demonstrated that the NK1R/SP complex serves as a target in a large variety of cancers, including pediatric malignancies such as neuroblastoma and hepatoblastoma [19,20,31,32,33]. This evidence concerns the gene TFF2 and neuroblastoma.